Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States ...

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

After our editorial, the agency relents to allow a Duchenne treatment.

Apellis Pharma (APLS) stock in focus as the FDA expands the label for its injectable therapy Empaveli to treat rare kidney ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

The FDA just approved gardenia (genipin) blue, a natural food dye, for certain foods and drinks. They’re also trying to expedite the ban of Red No. 3 before the January 15, 2027, deadline.

Corcept Therapeutics CORT announced that it has submitted a new drug application (NDA) to the FDA seeking approval for its lead pipeline candidate, relacorilant, for treating a new indication. The ...

The U.S. Food and Drug Administration on Monday approved a new blue color additive derived from the fruit of the gardenia, a flowering evergreen. The color is approved for use in sports drinks, ...

This isn't the first natural color that the FDA has approved this year.Key pointsOn Monday, July 14, the FDA announced that it has approved the use of the natural color additive gardenia (genipin) ...

On Monday, July 14, the FDA announced that it has approved the use of the natural color additive gardenia (genipin) blue for dying a variety of foods and drinks. This is the fourth natural color ...

Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from ...